KREJČÍ, Marta, Zdeněk ADAM, Andrea KŘIVANOVÁ, Luděk POUR, Michal HOLÁNEK, Viera SANDECKÁ, Jiří MAYER, Jiří VORLÍČEK and Roman HÁJEK. Up-front salvage treatment with melphalan 100 mg/m2 in fulminant progression of multiple myeloma and consolidation with novel drugs. In 14th Congress of the European Hematology Association. 2009.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Up-front salvage treatment with melphalan 100 mg/m2 in fulminant progression of multiple myeloma and consolidation with novel drugs
Authors KREJČÍ, Marta, Zdeněk ADAM, Andrea KŘIVANOVÁ, Luděk POUR, Michal HOLÁNEK, Viera SANDECKÁ, Jiří MAYER, Jiří VORLÍČEK and Roman HÁJEK.
Edition 14th Congress of the European Hematology Association, 2009.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30200 3.2 Clinical medicine
Country of publisher Italy
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
Keywords in English multiple myeloma; melphalan
Tags melphalan, multiple myeloma
Tags International impact
Changed by Changed by: Mgr. Anna Potáčová, Ph.D., učo 44190. Changed: 17/6/2009 07:56.
Links
NR9225, research and development projectName: Optimalizace léčby pacientů s mnohočetným myelomem v České republice
NR9317, research and development projectName: Prognostický význam klonálních chromosomových aberací při použití nových léčebných metod u mnohočetného myelomu
PrintDisplayed: 24/7/2024 12:23